Sandeep Gulati

Dr. Sandeep Gulati is a prolific inventor and technology leader with over 35 US patents spanning Quantum Resonance Interferometry (QRI), collision computing, and advanced sensor systems. With more than 25 years of experience, he has driven pioneering innovations in ultra-weak signal processing, AI, clinical decision systems, and machine learning for diverse fields including medical devices, genomics, remote sensing, and fintech. Notably, his patented Terminal Slider Control formalism enhanced closed-loop precision drug delivery and autonomous systems worldwide.

As CTO and VP – Clinical R&D and Platform Innovation at Peerbridge Health, Dr. Gulati leads the development of the Peerbridge CorMDx™ ambulatory ECG wireless patch, which delivers industry-leading 31+ arrhythmia detection, up to 30-day Holter monitoring, and real-time remote cardiac diagnostics. He is also spearheading the clinical commercialization of AI-powered, direct-from-ECG Apnea-Hypopnea Index (AHI) and Ejection Fraction (EF) prediction tools, expanding key capabilities for sleep apnea and heart failure management.

Previously, Dr. Gulati led NASA JPL’s Ultracomputing Technologies Group in Pasadena, CA, advancing machine learning, autonomy, and sensor fusion for national aerospace and defense programs. He founded ViaLogy Plc, inventing and commercializing QRI technology for genomics, drug discovery, and seismic analysis in oil and gas. As CTO of Aerolliance Corp, he developed software-defined radar for next-generation drone detection. Dr. Gulati has published over 80 technical papers.